PARP inhibitors for cancer therapy /

PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP-poly ADP ribose polymerase-in cancer therapy. The volume covers the history of the discovery of PARP and its role in DNA repair. Additionally, it describes the discovery of the PARP family, and includes a discus...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Curtin, Nicola J. (Editor), Sharma, Ricky A. (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing Imprint: Humana Press 2015.
Series:Cancer Drug Discovery and Development, 83
Subjects:
Online Access:Click here to view the full text content
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP-poly ADP ribose polymerase-in cancer therapy. The volume covers the history of the discovery of PARP and its role in DNA repair. Additionally, it describes the discovery of the PARP family, and includes a discussion of other DNA maintenance-associated PARPs. As well, the volume features a section on the accessible chemistry behind the development of inhibitors. PARP inhibitors-PARPi-are a group of pharmacological inhibitors that are particularly good targets for cancer therapy. PARP plays a pivotal role in DNA repair and may contribute to the therapeutic resistance to DNA-damaging agents used to treat cancer. Researchers have learned a great deal about the biology of PARP and how tumor-specific defects in DNA repair can be exploited by PARPi. The "synthetic lethality" of PARPi is an exciting concept for cancer therapy, and has led to heightened activity in this area.
Physical Description:1 online resource (xix, 591 pages) 108 illustrations, 85 illustrations in colour.
ISBN:9783319141510
ISSN:2196-9906 ;